With Viralytics not attending any other conferences before the vote goes ahead (so when will the MTICI trial update otherwise happen before the June sale?), I'm really not sure how BMS is going to be the saviour and swoop in and gazump Merck's bid.
Think it's time to cut and run....
VLA Price at posting:
$1.69 Sentiment: Hold Disclosure: Held